FDA Expands Use of Simulations Plus’ ADMET Predictor for Cosmetic Safety
Event summary
- FDA’s Cosmetics Regulatory Science Branch licensed Simulations Plus’ ADMET Predictor for cosmetic safety assessment.
- The platform uses AI/ML to predict endpoint properties and systemic exposure in animals and humans.
- This expands the FDA’s use of Simulations Plus technology beyond pharmaceuticals.
- The deal follows a 2024 collaboration with ICCS for animal-free safety assessment of cosmetics.
The big picture
The FDA’s adoption of ADMET Predictor underscores the growing role of AI-driven predictive modeling in regulatory science. This deal extends Simulations Plus’ reach beyond pharmaceuticals, signaling broader industry acceptance of computational safety assessment tools. The collaboration with ICCS further reinforces the shift toward animal-free testing methodologies in cosmetics.
What we're watching
- Regulatory Expansion
- How quickly Simulations Plus can replicate this FDA adoption in other regulatory bodies.
- Market Diversification
- Whether the company can sustain growth in non-pharmaceutical markets like cosmetics.
- Technology Validation
- The pace at which predictive modeling becomes a standard in cosmetic safety assessments.